Mr. Chris Dallin reports

ASEP MEDICAL HOLDINGS AMENDS AND REFILES ITS MANAGEMENT'S DISCUSSION & ANALYSIS FOR ITS YEAR ENDED DECEMBER 31, 2024

Asep Medical Holdings Inc. is refiling the Dec. 31, 2024, management's discussion and analysis (MD&A).

The amendments are summarized as follows:

• Additional section inserted in the MD&A titled intellectual properties, which provides disclosure of the patents and licences held by the company's subsidiary companies, ABT Innovations Inc. and Sepset Biosciences Inc.;
• Additional section inserted in the MD&A titled additional disclosure for venture issuers without significant revenue, which provides disclosure of the research and development activities being conducted by ABT on its therapeutic technology and Sepset on its diagnostic technology under development;
• Schedule A has been appended to the amended MD&A providing current disclosure relating to the audit committee required by Form 52-110F2;
• Schedule B has been appended to the amended MD&A providing current disclosure relating to corporate governance required y Form 58-101F2.

About Asep Medical Holdings Inc.

Asep Medical is a standout biotechnology research and development company based in Victoria, B.C., Canada. The company possesses a valuable portfolio of global patents for innovative diagnostic and therapeutic medical technologies. These technologies were developed over the past decade at the University of British Columbia under the guidance of Dr. Robert E.W. Hancock, one of the world's foremost microbiologists and the chief executive officer of Asep. Asep holds a controlling interest in two private subsidiary companies -- Sepset Biosciences (Asep's leading product, a sepsis diagnostic technology) and ABT Innovations (specializing in anti-biofilm technology). As the company's patented innovations address unmet medical needs, it presents a unique investment opportunity for both retail and institutional investors. It is also an attractive buyout target for a major global pharmaceutical operator.

We seek Safe Harbor.